血清连蛋白对非乳糜泻麸质敏感的診断性能
多中心研究纳入86例非乳糜泻麸质敏感(NCGS)、59例腹泻型肠易激综合征(IBS-D)、15例乳糜泻(CD)和25例无症状对照,评估血清连蛋白的诊断价值。连蛋白区分NCGS与IBS-D的准确率为81%,结合症状和性别后算法准确率提升至89%。
要点
- 血清连蛋白可作为NCGS的诊断生物标志物。
- 连蛋白联合症状和性别鉴别NCGS与IBS-D准确率达89%。
- 仅HLA-DQ2/8阳性的NCGS患者避食小麦后连蛋白显著下降。
核心结论
- 连蛋白可作为NCGS的诊断生物标志物,结合人口学和临床数据能高准确度区分NCGS与IBS-D。
研究设计与样本
- 多中心研究纳入86例自我报告或双盲确认的NCGS、59例IBS-D、15例CD和25例无症状对照,检测血清连蛋白并计算诊断效能。
主要发现
- 与无症状对照相比,NCGS(无论诊断方式)和CD患者连蛋白水平显著升高。
- NCGS和CD患者连蛋白水平均显著高于IBS-D患者。
- 自我报告NCGS的连蛋白水平高于双盲确认和未确认的NCGS。
- 连蛋白区分NCGS与IBS-D的诊断准确率为81%。
- 排除CD后,连蛋白联合症状和性别的诊断算法准确率提高至89%。
关键数值与推荐
- 连蛋白区分NCGS与IBS-D的准确率为81%。
- 联合连蛋白、症状和性别的算法准确率为89%。
- 6个月避食小麦仅在HLA-DQ2/8阳性的NCGS患者中显著降低连蛋白水平。
临床怎么用
- 血清连蛋白可用于NCGS的辅助诊断,联合症状和性别提高与IBS-D的鉴别准确率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Non-coeliac gluten sensitivity (NCGS) is characterised by intestinal and extraintestinal symptoms related to the ingestion of gluten-containing foods, in the absence of coeliac disease (CD) and wheat allergy. No biomarkers are available to diagnose NCGS and the gold standard double-blind placebo-controlled gluten challenge is clinically impractical. The aim of our work was to investigate the role of serum zonulin as a diagnostic biomarker of NCGS and to develop a diagnostic algorithm. DESIGN: In a multicentre study, we enrolled 86 patients with either self-reported or double-blind confirmed NCGS, 59 patients with diarrhoea-predominant IBS (IBS-D), 15 patients with CD and 25 asymptomatic controls (AC). Zonulin serum levels were assessed and the associated diagnostic power calculated. Clinical and symptomatic data were recorded. The effect of diet on zonulin levels was evaluated in a subgroup of patients with NCGS. RESULTS: Compared with ACs, the NCGS, irrespective of modality of diagnosis, and patients with CD had significantly increased levels of zonulin, as did both NCGS and patients with CD compared with participants with IBS-D. Self-reported NCGS showed increased zonulin levels compared with double-blind confirmed and not-confirmed NCGS. Six-month wheat avoidance significantly reduced zonulin levels only in HLA-DQ2/8-positive participants with NCGS. The diagnostic accuracy of zonulin levels in distinguishing NCGS from IBS-D was 81%. After exclusion of CD, a diagnostic algorithm combining zonulin levels, symptoms and gender improved the accuracy to 89%. CONCLUSION: Zonulin can be considered a diagnostic biomarker in NCGS and combined with demographic and clinical data differentiates NCGS from IBS-D with high accuracy. Wheat withdrawal was associated with a reduction in zonulin levels only in NCGS carrying HLA genotype.
引用
- Barbaro MR, Cremon C, Morselli-Labate AM, et al. Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity. Gut. 2020. PMID: 32060130. doi:10.1136/gutjnl-2019-319281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。